gila monster and glp 1 Science's 2023 Breakthrough: GLP-1R Agonists GLP-1 Receptor Agonists from Gila
Description
Itou M, Kawaguchi T, Taniguchi E, Sata M
GLP-1RAs may be an optimal option for ischemic stroke treatment
Pancreatitis and pancreatic cancer were reported in some studies but not in large CVOTs with relatively long duration of follow-up
No lab work is required by default, and the company reports that labs are requested in fewer than 1 in 1,000 cases
Most patients see their desired results within 4-6 weeks, but treatment duration varies depending on many factors
doi: 10.2337/db13-1660
